Griswold D E, Hillegass L M, Hill D E, Egan J W, Smith E F
Department of Immunology, Smith Kline and French Laboratories, King of Prussia, Pennsylvania 19406.
J Pharmacol Methods. 1988 Nov;20(3):225-35. doi: 10.1016/0160-5402(88)90065-4.
A method to quantitate both creatine phosphokinase (CPK) and myeloperoxidase (MPO) activity from the same cardiac tissue homogenate preparation is described. Depletion of CPK specific activity is used to quantitate myocardial infarct size, while MPO activity is utilized as a marker for polymorphonuclear leukocyte and monocyte infiltration into inflammatory sites. However, the standard assay systems are not compatible, necessitating the use of different groups of animals for these two parameters. This leads to an increase in cost, effort, and variability. The described method utilized a standard CPK methodology. It was found that interference in the MPO assay was likely caused by 2-mercaptoethanol present in the homogenate buffer (IC50 = 90 microM). Washing of the 30 K X g pellet followed by rehomogenization restored the MPO activity. Negligible MPO activity was found in the original supernatant or washes. Through the use of this technique, MPO activity was measured in the hearts of myocardial infarcted animals. The results indicated that MPO activity generated from CPK homogenate pellets compared favorably to the activity seen using standard methodology homogenates. The procedure described thus allowed the simultaneous determination of myocardial CPK specific activity and MPO activity, resulting in decreased animal usage and potentially less variability.
本文描述了一种从同一心脏组织匀浆制剂中定量肌酸磷酸激酶(CPK)和髓过氧化物酶(MPO)活性的方法。CPK比活性的降低用于定量心肌梗死面积,而MPO活性用作多形核白细胞和单核细胞浸润到炎症部位的标志物。然而,标准检测系统不兼容,这使得这两个参数需要使用不同组的动物。这导致成本、工作量和变异性增加。所描述的方法采用了标准的CPK方法。发现MPO检测中的干扰可能是由匀浆缓冲液中存在的2-巯基乙醇引起的(IC50 = 90 microM)。洗涤30 K X g沉淀后再匀浆可恢复MPO活性。在原始上清液或洗涤液中发现的MPO活性可忽略不计。通过使用该技术,在心肌梗死动物的心脏中测量了MPO活性。结果表明,与使用标准方法匀浆所见的活性相比,CPK匀浆沉淀产生的MPO活性良好。因此,所描述的程序允许同时测定心肌CPK比活性和MPO活性,从而减少动物使用量并可能降低变异性。